Pharmacodynamics of variable patient compliance: implications for pharmaceutical value
Author:
- J UrquhartJUJ Urquhart
- 7 September 1998
- journal article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 33 (3) , 207-219
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Can drug delivery systems deliver value in the new pharmaceutical marketplace?British Journal of Clinical Pharmacology, 1997
- Role of duration of diuretic effect in preventing sodium retention*Clinical Pharmacology & Therapeutics, 1997
- Facilitated analysis of data on drug regimen complianceStatistics in Medicine, 1997
- The Electronic Medication Event MonitorClinical Pharmacokinetics, 1997
- MEDICATION COMPLIANCE AS A FEATURE IN DRUG DEVELOPMENTAnnual Review of Pharmacology and Toxicology, 1997
- Persistence of anti‐hypertensive effect after ‘missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half‐lifeBritish Journal of Clinical Pharmacology, 1996
- Differential Effects of a Missed Dose of Trandolapril and Enalapril on Blood Pressure Control in Hypertensive PatientsJournal of Cardiovascular Pharmacology, 1995
- A STUDY DESIGN FOR COMPARING THE EFFECTS OF MISSING DAILY DOSES OF ANTIHYPERTENSIVE DRUGSAmerican Journal of Therapeutics, 1994
- ChronobiologyaAnnals of the New York Academy of Sciences, 1991
- Comparison of withdrawal phenomena after propranolol, metoprolol, and pindololAmerican Heart Journal, 1982